5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 161.30▲ | 160.50▲ |
MA10 | N/A | N/A | N/A | 161.45▲ | 159.25▲ |
MA20 | N/A | N/A | N/A | 160.77▲ | 153.82▲ |
MA50 | N/A | N/A | N/A | 158.29▲ | 152.23▲ |
MA100 | N/A | N/A | N/A | 153.52▲ | 147.46▲ |
MA200 | N/A | N/A | N/A | 152.13▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.185▼ | 1.034▲ |
RSI | N/A | N/A | N/A | 61.987▲ | 64.973▲ |
STOCH | N/A | N/A | N/A | 47.953 | 91.974▲ |
WILL %R | N/A | N/A | N/A | 0.000▲ | 0.000▲ |
CCI | N/A | N/A | N/A | 77.859 | 82.778 |
Wednesday, March 27, 2024 05:59 AM
The best high-yield savings accounts help you grow funds faster than average accounts. The products featured on this page have annual percentage yields, or APYs, of up to 5% or more. That is many ...
|
Wednesday, March 27, 2024 04:57 AM
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel targeted therapeutics for cancer in the United States. Its clinical stage ...
|
Tuesday, March 26, 2024 02:49 AM
Over a decade of editorial experience across a number of publications and more than 60 countries visited have given Dylan Pearl a wealth of travel knowledge, and the tools to effectively ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
27/03/24 | 161.51 | 162.50 | 161.51 | 162.50 | 1,135 |
26/03/24 | 160.32 | 160.87 | 160.32 | 160.50 | 1,449 |
25/03/24 | 160.43 | 161.21 | 160.43 | 160.50 | 1,069 |
22/03/24 | 161.50 | 162.10 | 161.50 | 161.50 | 362 |
21/03/24 | 161.46 | 161.77 | 161.46 | 161.50 | 241 |
20/03/24 | 161.50 | 162.01 | 161.50 | 161.50 | 1,221 |
19/03/24 | 161.83 | 162.11 | 161.2123 | 161.50 | 3,085 |
18/03/24 | 161.85 | 162.50 | 161.85 | 162.50 | 419 |
15/03/24 | 160.50 | 160.53 | 160.50 | 160.50 | 384 |
14/03/24 | 161.84 | 162.00 | 161.84 | 162.00 | 1,124 |
|
|
||||
|
|
||||
|
|